Atrial septal defect closure as second-line therapy in refractory heart failure: a successful case report in a 6-year-old child with phosphoglucomutase 1 deficiency (PGM1-CDG)
In selected patients with impaired LV compliance, ASD closure may offer a life-saving therapeutic option. Haemodynamic evaluation with balloon occlusion testing is essential to evaluate closure feasibility and determine the potential need of using a fenestrated device.
Authors
- Céline Grunenwald (ORCID: https://orcid.org/0009-0001-3003-7723)
- Oscar Werner (ORCID: https://orcid.org/0000-0002-3741-0498)
- Alban‐Elouen Baruteau (ORCID: https://orcid.org/0000-0003-2548-7858)
- Sylvain Mimoun
- Bruno Lefort
Institutions
- Université de Tours (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Clinical Investigation Center Plurithematic Tours (FR)
- Centre d'Investigation Clinique de Nantes (FR)
- Institut du Thorax (FR)
- Nantes Université (FR)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1093/ehjcr/ytaf583
- Primary Topic
- Cardiovascular and Diving-Related Complications
- Type
- article
- Field-Weighted Citation Impact
- 0.00